Press Releases

Indica Labs and Paige Forge Strategic Partnership to Expand Integrated AI for Anatomic Pathology Labs

Indica Labs and Paige have formed a non-exclusive partnership aimed at integrating Paige’s Diagnostic AI models into Indica’s robust Anatomic Pathology workflow management software, HALO AP®.

International Consortium to Revolutionize Viral Vector Manufacturing

Abselion has announced the collaboration of leading biotechnology companies and research organizations in UK and Canada to develop next-generation cell platform for viral vector production.

Biopharma PEG Expands Multi-Arm PEG Product Line for Medical and Biopharma Applications

Phastar named in 2024 Environment 100 List

Phastar named in 2024 Environment 100 List Phastar continues to lead the CRO industry in corporate responsibility as CEO Graham Clark is named in list of trailblazers, innovators and visionaries.

PathAI Announces Launch of AI-based Measurement of Metabolic Dysfunction-Associated Steatohepatitis ("AIM-MASH") on the AISight Image Management System

PathAI, a global leader in artificial intelligence (AI) and digital pathology solutions, is proud to announce the launch of its AIM-MASH product on the AISightⓇ1 Image Management System (IMS). This product provides advanced AI-based measurement (AIM) to support the analysis of MASH Clinical Research Network (CRN) Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Activity Score (MAS) component grades and fibrosis staging. The launch of AIM-MASH on AISight aims to increase the reproducibility and scalability of pathologists' assessments and management of MASH cases, which are projected to reach 27 million in the US alone by 2030.

eClinical Solutions Introduces Protocol Deviations Among New Product Innovations Boosting Operational Success for Clinical Trials

eClinical Solutions announced newly released product enhancements and AI-enabled functionality within the elluminate Clinical Data Cloud ®. Recent platform updates offer clinical teams increased oversight and efficiency amid trial complexity and advance the AI technology footprint of life sciences organizations.

Abzena Supplies Clinical Trial Material for Angiex’s Phase I Study of AGX101, a First-in-Class TM4SF1-directed ADC

Brijesh Patel Named New CEO at ECI

ECI (Enhanced Compliance Inc.), a leading provider of regulatory, quality and engineering services and solutions for the life sciences industries, today announced the appointment of Brijesh Patel as the company’s new Chief Executive Officer (CEO), replacing Hoyt Randall Smith, who has announced his retirement.

TEDDY Selects Infinity Bio to Provide Antibody Reactome Services for Large Study

Infinity Bio has been chosen by The Environmental Determinants of Diabetes in the Young (TEDDY) study to provide antibody reactome services. This collaboration aims to advance the understanding of environmental factors contributing to type 1 diabetes. Infinity Bio’s innovative technology will be used to analyze antibody responses, offering critical insights for diabetes research. This partnership signifies a major step forward in biomedical research, with the potential to enhance diabetes prevention and treatment strategies.

Cresset® collaborates with global leaders Enamine to enable the design of exciting new Targeted Protein Degraders

Rho names renowned neurologist Andrew Feigin, MD, as Chief Medical Officer

Rho, a full-service contract research organization (CRO), has appointed leading neurologist Dr. Andrew Feigin as its new chief medical officer (CMO). In this pivotal global role, Dr. Feigin will provide strategic medical and operational expertise across multiple therapeutic areas, ensuring the integrity and safety of Rho’s clinical trials. Dr. Feigin's career is marked by groundbreaking contributions to neurology and clinical research. He served as the site principal investigator on more than 30 clinical trials, notably spearheading the first phase 1 clinical trial using gene therapy for Parkinson's disease. His prolific contributions to the field include over 150 peer-reviewed articles and numerous advisory board positions.

Indica Labs Announces Launch of AI-Powered Macrodissection Suite to Advance Molecular Pathology Workflows

Indica Labs has announced the launch of Lung Macrodissect AI, a groundbreaking tool that revolutionizes slide macrodissection and molecular pathology workflows.

Sequence Biotech LLC Assumes Full Distribution of Sorenson Benchtop Pipettor

Sequence Biotech LLC assumes Full Distribution of Sorenson Benchtop Pipettor. The 96 / 384 channel benchtop pipettor that has been used by industry giants for over a decade. Sequence Biotech is the original manufacturer of the "Sorenson Benchtop Pipettor."

Clinion Wins The Clinical Trials Arena Excellence Award 2024 for Innovation

Clinion, a Lifescience technology company based out of the US, UK and India, has won a category award in the 2024 Clinical Trials Arena Excellence Awards

Creative Enzymes Redefines Sustainability in Enzyme Innovation with Yeast-Fermented Vegan Collagen

Creative BioMart Expands Native Proteins Offering to Advance Scientific Research and Discovery

Inizio Engage and Nye Health form a strategic alliance to enhance patient support and outcomes

Creative Enzymes Unveils Semaglutide, a Promising Solution for Comprehensive Diabetes Management

Peerbridge Health Launches EF-ACT Pivotal Trial to Determine Ejection Fraction Severity from AI-Enabled Remote ECG Wearable

Peerbridge Health Launches EF-ACT Pivotal Trial to Determine Ejection Fraction Severity from AI-Enabled Remote ECG Wearable

Trial Approval for New Pacemaker Aiming to Boost Recovery in Heart Failure

Ceryx Medica has announced the trial approval for Cysoni-XT, a new temporary cardiac pacemaker aiming to boost recovery in heart failure.